"10.1371_journal.pone.0097868","plos one","2014-06-04T00:00:00Z","Laura Simon-Szabó; Márton Kokas; József Mandl; György Kéri; Miklós Csala","Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary; MTA-SE Pathobiochemistry Research Group, Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary; Vichem Chemie Research Ltd., Budapest, Hungary","Conceived and designed the experiments: GK MC. Performed the experiments: LSS MK. Analyzed the data: LSS MK JM GK MC. Contributed to the writing of the manuscript: MC LSS MC.","György Kéri is the founder of and presently Chief Executive Officer and Chief Scientific Officer at Vichem Chemie Research Ltd. The companys profile is not related to diabetes, β-cell protection or metformin, and therefore this employment does not raise any competing interests with regards to the present article. The authors hereby declare that this does not alter their adherence to PLOS ONE policies on sharing data and materials.","2014","06","Laura Simon-Szabó","LSS",5,TRUE,2,2,5,NA,TRUE,TRUE,FALSE,0,NA,FALSE
